Juliane Glaser

Dr. Juliane Glaser is a Group Leader at the Max Planck Institute of Immunobiology & Epigenetics, leading the Lab Glaser. Her research focuses on epigenetic mechanisms governing mammalian embryonic development, particularly the role of transposable elements (TEs) in both healthy and pathological developmental outcomes. Her work bridges genomic regulation and morphological phenotypes, leveraging mouse models for mechanistic insights.

Glaser employs CRISPR/Cas9 genome engineering, high-throughput sequencing (including single-cell and long-read technologies), and embryonic imaging to study TE contributions to lineage commitment, tissue shaping, and congenital diseases. Her lab develops tools to systematically assess TE impacts on developmental gene regulation and cell states.

Her research emphasizes translating findings from mouse models to human genomic datasets, aiming to uncover links between TE activity and congenital disorders. Current efforts include characterizing TE-induced limb malformations and exploring TE roles in organogenesis. No scientific awards are explicitly listed, though her impactful publications reflect recognition in the field.

Advising and grants are not detailed in the provided text, but her lab actively seeks candidates for open positions. The Lab Glaser collaborates broadly, integrating genomic, molecular, and developmental biology approaches to redefine understanding of (epi)genomic drivers in embryogenesis.